Concord Medical Co Ltd(TW:6518)
NT$29.85-0.15 (-0.50%)
TW:6518
Concord Medical Co Ltd financials statements
NT$29.85
At close:-0.15 (-0.50%)
Concord Medical Co Ltd (6518) Ratios
Concord Medical Co Ltd Ratios
TW:6518's free cash flow for Q2 2026 was NT$64.06M. For the 2026 fiscal year, TW:6518's free cash flow was decreased by NT$-1.36M and operating cash flow was NT$65.42M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.78 | 2.21 | 2.26 | 2.27 | 1.99 |
| Quick Ratio | 1.76 | 2.20 | 2.25 | 2.25 | 1.95 |
| Cash Ratio | 0.37 | 0.38 | 0.39 | 0.83 | 0.74 |
| Solvency Ratio | 0.33 | 0.29 | 0.26 | 0.27 | 0.29 |
| Operating Cash Flow Ratio | 0.47 | 0.52 | 0.40 | 0.52 | 0.51 |
| Short-Term Operating Cash Flow Coverage | 2.81 | 16.56 | 12.09 | 9.15 | 5.16 |
| Net Current Asset Value | NT$ 135.38M | NT$ 164.47M | NT$ 167.63M | NT$ 214.11M | NT$ 89.04M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.18 | 0.19 | 0.17 | 0.20 |
| Debt-to-Equity Ratio | 0.25 | 0.30 | 0.32 | 0.29 | 0.34 |
| Debt-to-Capital Ratio | 0.20 | 0.23 | 0.24 | 0.23 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.05 | 0.05 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.68 | 1.67 | 1.69 | 1.75 | 1.70 |
| Debt Service Coverage Ratio | 2.38 | 11.11 | 9.76 | 6.36 | 4.32 |
| Interest Coverage Ratio | 18.69 | 17.40 | 15.61 | 18.44 | 7.83 |
| Debt to Market Cap | 0.06 | 0.05 | 0.05 | 0.02 | 0.06 |
| Interest Debt Per Share | 5.42 | 6.43 | 6.57 | 6.04 | 8.85 |
| Net Debt to EBITDA | 0.34 | 0.66 | 0.76 | -0.34 | 0.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 13.89% | 12.32% | 12.26% | 12.27% | 9.27% |
| EBIT Margin | 7.55% | 7.42% | 6.97% | 7.62% | 6.44% |
| EBITDA Margin | 16.36% | 17.11% | 16.50% | 16.13% | 19.51% |
| Operating Profit Margin | 7.55% | 6.95% | 6.59% | 7.29% | 5.07% |
| Pretax Profit Margin | 8.59% | 7.02% | 6.54% | 7.22% | 5.79% |
| Net Profit Margin | 7.04% | 5.57% | 5.13% | 5.70% | 4.65% |
| Continuous Operations Profit Margin | 7.04% | 5.57% | 5.13% | 5.69% | 4.65% |
| Net Income Per EBT | 82.01% | 79.38% | 78.39% | 78.88% | 80.39% |
| EBT Per EBIT | 113.82% | 101.00% | 99.29% | 99.14% | 114.20% |
| Return on Assets (ROA) | 5.57% | 4.26% | 3.71% | 4.31% | 3.18% |
| Return on Equity (ROE) | 9.33% | 7.11% | 6.28% | 7.54% | 5.39% |
| Return on Capital Employed (ROCE) | 8.24% | 7.04% | 6.32% | 7.39% | 4.60% |
| Return on Invested Capital (ROIC) | 6.35% | 5.38% | 4.77% | 5.59% | 3.51% |
| Return on Tangible Assets | 5.66% | 4.27% | 3.72% | 4.32% | 3.18% |
| Earnings Yield | 7.71% | 5.76% | 4.92% | 6.44% | 7.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.18 | 2.95 | 2.72 | 2.83 | 2.38 |
| Payables Turnover | 3.39 | 3.45 | 3.17 | 3.41 | 3.33 |
| Inventory Turnover | 88.70 | 195.89 | 286.02 | 125.95 | 71.56 |
| Fixed Asset Turnover | 6.97 | 5.94 | 6.10 | 7.55 | 1.40 |
| Asset Turnover | 0.79 | 0.76 | 0.72 | 0.76 | 0.68 |
| Working Capital Turnover Ratio | 3.16 | 2.54 | 2.27 | 2.76 | 3.88 |
| Cash Conversion Cycle | 11.13 | 20.05 | 20.46 | 24.75 | 49.00 |
| Days of Sales Outstanding | 114.81 | 123.94 | 134.38 | 128.98 | 153.52 |
| Days of Inventory Outstanding | 4.12 | 1.86 | 1.28 | 2.90 | 5.10 |
| Days of Payables Outstanding | 107.80 | 105.75 | 115.19 | 107.13 | 109.62 |
| Operating Cycle | 118.93 | 125.80 | 135.65 | 131.88 | 158.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.68 | 4.47 | 3.39 | 4.64 | 5.49 |
| Free Cash Flow Per Share | 3.67 | 2.17 | 0.70 | 3.50 | 4.61 |
| Dividend Paid and CapEx Coverage Ratio | 2.23 | 1.36 | 0.92 | 2.82 | 4.30 |
| Capital Expenditure Coverage Ratio | 4.65 | 1.95 | 1.26 | 4.06 | 6.26 |
| Operating Cash Flow Coverage Ratio | 0.88 | 0.71 | 0.52 | 0.78 | 0.63 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.17 | 0.14 | 0.17 | 0.19 |
| Free Cash Flow Yield | 14.01% | 8.43% | 2.71% | 14.81% | 25.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.97 | 17.32 | 20.31 | 15.53 | 13.14 |
| Price-to-Sales (P/S) Ratio | 0.91 | 0.97 | 1.04 | 0.88 | 0.61 |
| Price-to-Book (P/B) Ratio | 1.21 | 1.23 | 1.27 | 1.17 | 0.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.14 | 11.87 | 36.88 | 6.75 | 3.90 |
| Price-to-Operating Cash Flow Ratio | 5.60 | 5.78 | 7.67 | 5.09 | 3.28 |
| Price-to-Earnings Growth (PEG) Ratio | 0.36 | 1.06 | -1.29 | 1.42 | 0.18 |
| Enterprise Value Multiple | 5.92 | 6.31 | 7.08 | 5.14 | 3.25 |
| Enterprise Value | 934.35M | 961.11M | 973.02M | 737.41M | 468.85M |
| EV to EBITDA | 5.92 | 6.31 | 7.08 | 5.14 | 3.25 |
| EV to Sales | 0.97 | 1.08 | 1.17 | 0.83 | 0.63 |
| EV to Free Cash Flow | 7.57 | 13.26 | 41.33 | 6.33 | 4.06 |
| EV to Operating Cash Flow | 5.94 | 6.46 | 8.59 | 4.77 | 3.41 |
| Tangible Book Value Per Share | 21.80 | 20.84 | 20.31 | 21.29 | 25.39 |
| Shareholders’ Equity Per Share | 21.65 | 20.92 | 20.39 | 20.15 | 25.46 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.21 | 0.22 | 0.21 | 0.20 |
| Revenue Per Share | 28.68 | 26.70 | 24.95 | 26.68 | 29.51 |
| Net Income Per Share | 2.02 | 1.49 | 1.28 | 1.52 | 1.37 |
| Tax Burden | 0.82 | 0.79 | 0.78 | 0.79 | 0.80 |
| Interest Burden | 1.14 | 0.95 | 0.94 | 0.95 | 0.90 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.06 | 0.05 | 0.06 | 0.05 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.33 | 2.38 | 2.65 | 3.05 | 4.00 |
Currency in TWD
